
Masoud H. Noori
Examiner (ID: 3784, Phone: (571)272-2185 , Office: P/2855 )
| Most Active Art Unit | 2855 |
| Art Unit(s) | 2855, 2214, 2856, 2616 |
| Total Applications | 3955 |
| Issued Applications | 3448 |
| Pending Applications | 170 |
| Abandoned Applications | 350 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19026285
[patent_doc_number] => 11925624
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-12
[patent_title] => Methods of administering anti-fibrotic therapy
[patent_app_type] => utility
[patent_app_number] => 17/528537
[patent_app_country] => US
[patent_app_date] => 2021-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 12864
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17528537
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/528537 | Methods of administering anti-fibrotic therapy | Nov 16, 2021 | Issued |
Array
(
[id] => 18228482
[patent_doc_number] => 20230067476
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => 3-(5-HYDROXY-1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/520857
[patent_app_country] => US
[patent_app_date] => 2021-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 174161
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 954
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17520857
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/520857 | 3-(5-hydroxy-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof | Nov 7, 2021 | Issued |
Array
(
[id] => 18860197
[patent_doc_number] => 20230414631
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => COMPOSITION FOR PREVENTING OR TREATING TNF-alpha-RELATED DISEASE, COMPRISING HYDROFLUMETHIAZIDE AS ACTIVE INGREDIENT
[patent_app_type] => utility
[patent_app_number] => 18/035627
[patent_app_country] => US
[patent_app_date] => 2021-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6842
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18035627
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/035627 | COMPOSITION FOR PREVENTING OR TREATING TNF-alpha-RELATED DISEASE, COMPRISING HYDROFLUMETHIAZIDE AS ACTIVE INGREDIENT | Nov 4, 2021 | Pending |
Array
(
[id] => 20142780
[patent_doc_number] => 12377095
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-05
[patent_title] => Use of ligustrazine nitrone derivatives in treatment and prevention of diabetic complication diseases
[patent_app_type] => utility
[patent_app_number] => 17/300777
[patent_app_country] => US
[patent_app_date] => 2021-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 23
[patent_no_of_words] => 6369
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17300777
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/300777 | Use of ligustrazine nitrone derivatives in treatment and prevention of diabetic complication diseases | Nov 2, 2021 | Issued |
Array
(
[id] => 18877381
[patent_doc_number] => 20240000750
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-04
[patent_title] => METHOD FOR PREPARING CRYSTALLINE PARTICLES OF 1-(3-CYANO-1-ISOPROPYL-INDOLE-5-YL)PYRAZOLE-4-CARBOXYLIC ACID, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME
[patent_app_type] => utility
[patent_app_number] => 18/251646
[patent_app_country] => US
[patent_app_date] => 2021-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6720
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18251646
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/251646 | METHOD FOR PREPARING CRYSTALLINE PARTICLES OF 1-(3-CYANO-1-ISOPROPYL-INDOLE-5-YL)PYRAZOLE-4-CARBOXYLIC ACID, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME | Nov 1, 2021 | Pending |
Array
(
[id] => 17385480
[patent_doc_number] => 20220033332
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-03
[patent_title] => Chromium-Catalyzed Production of Alcohols From Hydrocarbons
[patent_app_type] => utility
[patent_app_number] => 17/501020
[patent_app_country] => US
[patent_app_date] => 2021-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23766
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17501020
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/501020 | Chromium-catalyzed production of alcohols from hydrocarbons | Oct 13, 2021 | Issued |
Array
(
[id] => 17520443
[patent_doc_number] => 20220106292
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-07
[patent_title] => SMALL MOLECULE INHIBITORS OF SHARED EPITOPE-CALRETICULIN INTERACTIONS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/501572
[patent_app_country] => US
[patent_app_date] => 2021-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11007
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17501572
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/501572 | Small molecule inhibitors of shared epitope-calreticulin interactions and methods of use | Oct 13, 2021 | Issued |
Array
(
[id] => 19060106
[patent_doc_number] => 11939314
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-26
[patent_title] => Quinolin-2-one derivatives
[patent_app_type] => utility
[patent_app_number] => 17/499278
[patent_app_country] => US
[patent_app_date] => 2021-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39274
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 331
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17499278
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/499278 | Quinolin-2-one derivatives | Oct 11, 2021 | Issued |
Array
(
[id] => 18861780
[patent_doc_number] => 20230416215
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => OXIDATIVE PRETREATMENT OF CARBOHYDRATE DEHYDRATION PRODUCTS COMPRISING HUMINS
[patent_app_type] => utility
[patent_app_number] => 18/248846
[patent_app_country] => US
[patent_app_date] => 2021-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13087
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18248846
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/248846 | OXIDATIVE PRETREATMENT OF CARBOHYDRATE DEHYDRATION PRODUCTS COMPRISING HUMINS | Oct 10, 2021 | Pending |
Array
(
[id] => 18176910
[patent_doc_number] => 20230037639
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-09
[patent_title] => 3-(5-AMINO-1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/493055
[patent_app_country] => US
[patent_app_date] => 2021-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 106350
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 813
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17493055
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/493055 | 3-(5-amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione derivatives and uses thereof | Oct 3, 2021 | Issued |
Array
(
[id] => 18895141
[patent_doc_number] => 20240010626
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-11
[patent_title] => METHOD FOR PRODUCING CARBONYLAMINOFURANS
[patent_app_type] => utility
[patent_app_number] => 18/247795
[patent_app_country] => US
[patent_app_date] => 2021-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2166
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 139
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18247795
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/247795 | METHOD FOR PRODUCING CARBONYLAMINOFURANS | Oct 3, 2021 | Pending |
Array
(
[id] => 17343567
[patent_doc_number] => 20220009898
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-13
[patent_title] => METHOD FOR PRODUCING HETEROCYCLIDENE ACETAMIDE DERIVATIVE
[patent_app_type] => utility
[patent_app_number] => 17/486265
[patent_app_country] => US
[patent_app_date] => 2021-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26022
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17486265
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/486265 | Method for producing heterocyclidene acetamide derivative | Sep 26, 2021 | Issued |
Array
(
[id] => 17335926
[patent_doc_number] => 20220002257
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-06
[patent_title] => PRODUCTION METHOD FOR HEMIAMINAL COMPOUND AND PRODUCTION METHOD FOR HETEROCYCLIC COMPOUND
[patent_app_type] => utility
[patent_app_number] => 17/480822
[patent_app_country] => US
[patent_app_date] => 2021-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6748
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17480822
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/480822 | Production method for hemiaminal compound and production method for heterocyclic compound | Sep 20, 2021 | Issued |
Array
(
[id] => 18752375
[patent_doc_number] => 20230355607
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-09
[patent_title] => NEW MEDICAL USE OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (CFTR) MODULATORS
[patent_app_type] => utility
[patent_app_number] => 18/025979
[patent_app_country] => US
[patent_app_date] => 2021-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8825
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18025979
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/025979 | NEW MEDICAL USE OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (CFTR) MODULATORS | Sep 16, 2021 | Pending |
Array
(
[id] => 18603380
[patent_doc_number] => 11744820
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-05
[patent_title] => Inhibitors of microbially induced amyloid
[patent_app_type] => utility
[patent_app_number] => 17/447178
[patent_app_country] => US
[patent_app_date] => 2021-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 67
[patent_no_of_words] => 38312
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17447178
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/447178 | Inhibitors of microbially induced amyloid | Sep 7, 2021 | Issued |
Array
(
[id] => 17953477
[patent_doc_number] => 11479568
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-25
[patent_title] => Silacrown ethers, pharmaceutical compositions thereof, and therapeutic applications thereof
[patent_app_type] => utility
[patent_app_number] => 17/464301
[patent_app_country] => US
[patent_app_date] => 2021-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4478
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17464301
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/464301 | Silacrown ethers, pharmaceutical compositions thereof, and therapeutic applications thereof | Aug 31, 2021 | Issued |
Array
(
[id] => 18793881
[patent_doc_number] => 11827633
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-11-28
[patent_title] => Substituted pyrido[3,4-b]indoles for the treatment of cartilage disorders
[patent_app_type] => utility
[patent_app_number] => 17/409513
[patent_app_country] => US
[patent_app_date] => 2021-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43795
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 648
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17409513
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/409513 | Substituted pyrido[3,4-b]indoles for the treatment of cartilage disorders | Aug 22, 2021 | Issued |
Array
(
[id] => 17274357
[patent_doc_number] => 20210380555
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-09
[patent_title] => PROCESS FOR PREPARING 6-(1-ACRYLOYLPIPERIDIN-4-YL)-2-(4-PHENOXYPHENYL)NICOTINAMIDE
[patent_app_type] => utility
[patent_app_number] => 17/407340
[patent_app_country] => US
[patent_app_date] => 2021-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3316
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17407340
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/407340 | Process for preparing 6-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)nicotinamide | Aug 19, 2021 | Issued |
Array
(
[id] => 18700016
[patent_doc_number] => 11786502
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-17
[patent_title] => Method of treatment
[patent_app_type] => utility
[patent_app_number] => 17/407921
[patent_app_country] => US
[patent_app_date] => 2021-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 1311
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17407921
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/407921 | Method of treatment | Aug 19, 2021 | Issued |
Array
(
[id] => 17273374
[patent_doc_number] => 20210379572
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-09
[patent_title] => NOVEL CATALYST SUPPORTS - COMPOSITION AND PROCESS OF MANUFACTURE
[patent_app_type] => utility
[patent_app_number] => 17/405245
[patent_app_country] => US
[patent_app_date] => 2021-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9592
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17405245
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/405245 | Catalyst supports--composition and process of manufacture | Aug 17, 2021 | Issued |